🔎 Trials Near Me

Akèy › Leksemi mieloïd egi › Georgia › Atlanta

Etid klinik pou Leksemi mieloïd egi nan Atlanta, GA

31 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Atlanta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Ap rekriteFaz 1
  • Children'S Healthcare Of Atlanta - Arthur M. Blank Hospital /ID# 275740, Atlanta
6 Months – 17 Years · Tout sèks · Mizajou Oct 5, 2026 · NCT07306832

Ivosidenib as Post-HSCT Maintenance for AML

Ap rekriteFaz 2
  • Emory University Hospital, Atlanta
Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06707493

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Ap rekriteFaz 1
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Jiska laj 21 · Tout sèks · Mizajou Oct 5, 2026 · NCT07012044

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Atlanta VA Medical Center, Decatur · 6 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Ap rekriteEtid obsèvasyon
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Laj 0 a 38 · Tout sèks · Mizajou Oct 1, 2026 · NCT06131801

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Ap rekriteFaz 1
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06484062

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Ap rekriteFaz 1
  • Emory University, Atlanta
Laj 12 a 78 · Tout sèks · Mizajou Sep 29, 2026 · NCT03802695

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Ap rekriteFaz 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
6 Months – 21 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Ap rekriteFaz 1/2
  • Emory Winship Cancer Institute, Atlanta
30 Days · Tout sèks · Mizajou Sep 16, 2026 · NCT04065399

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Ap rekriteFaz 2
  • Winship Cancer Institute - Emory University, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Ap rekriteFaz 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Laj 1 a 25 · Tout sèks · Mizajou Sep 4, 2026 · NCT07022678

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Ap rekriteFaz 3
  • US-Atlanta GA-EMORY, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06652438

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

Ap rekriteFaz 3
  • US-Atlanta GA-EMORY, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07223814

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Ap rekriteFaz 3
  • Children's Healthcare of Atlanta, Atlanta
29 Days – 21 Years · Tout sèks · Mizajou Aug 24, 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Ap rekriteFaz 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06001788

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Ap rekriteFaz 1
  • Children's Healthcare of Atlanta, Atlanta
Laj 1 a 30 · Tout sèks · Mizajou Aug 3, 2026 · NCT06177067

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Ap rekriteFaz 1Volontè an sante akeyi
  • Northside Hospital, Atlanta
Laj 18 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07020533

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Ap rekriteFaz 3
  • Emory University - Winship Cancer Institute (WCI), Atlanta
Laj 18 a 75 · Tout sèks · Mizajou Jul 17, 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • Children's Healthcare of Atlanta, Atlanta
  • Northside Hospital, Atlanta
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Ap rekriteFaz 1/2
  • Emory Winship Cancer Institute, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT04068597

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Ap rekriteFaz 1
  • Winship Cancer Institute / Emory University, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT05768932

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Ap rekriteFaz 2/3
  • University of Emory - Winship Cancer Institute, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT04256317

Pilot Imaging Study of Leukemia

Ap rekriteFaz 1
  • Emory University, Atlanta
Laj 4 a 80 · Tout sèks · Mizajou Apr 23, 2026 · NCT03633955

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Ap rekriteFaz 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT05735184

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Ap rekriteFaz 2Volontè an sante akeyi
  • Northside Hospital, Atlanta
Laj 18 a 75 · Tout sèks · Mizajou Mar 10, 2026 · NCT06059391

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Ap rekriteFaz 1
  • Emory University Hospital, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT05143996

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

Ap rekriteFaz 1
  • Emory University - WINSHIP Cancer Center, Atlanta
  • Emory University, Children's Healthcare of Atlanta, Atlanta
Laj 12 ak plis · Tout sèks · Mizajou Jan 8, 2026 · NCT04872478

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

Ap rekriteFaz 1
  • Blood and Marrow Transplant Group of Georgia, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Oct 31, 2025 · NCT06549790

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Ap rekriteVolontè an sante akeyi
  • Emory University, Atlanta
Laj 18 a 120 · Tout sèks · Mizajou Jul 25, 2025 · NCT05237258

Etid Leksemi mieloïd egi nan lòt vil

Lòt etid nan Atlanta

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.